Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Relmada Therapeutics, Inc. - Common Stock
(NQ:
RLMD
)
4.270
-0.050 (-1.16%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Relmada Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Stay updated with the stocks that are on the move in today's pre-market session.
↗
April 24, 2025
Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
April 24, 2025
Via
Benzinga
Why ServiceNow Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
↗
April 24, 2025
Via
Benzinga
Insights Ahead: Relmada Therapeutics's Quarterly Earnings
↗
March 26, 2025
Via
Benzinga
A Look Ahead: Relmada Therapeutics's Earnings Forecast
↗
November 06, 2024
Via
Benzinga
Recap: Relmada Therapeutics Q4 Earnings
↗
March 19, 2024
Via
Benzinga
Earnings Outlook For Relmada Therapeutics
↗
March 18, 2024
Via
Benzinga
Top movers in Wednesday's after hours session
↗
April 23, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
April 23, 2025
Via
Benzinga
Top movers in Wednesday's session
↗
April 23, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Earnings Outlook For Relmada Therapeutics
↗
November 07, 2023
Via
Benzinga
On Wednesday, there are stocks with unusual volume. Let's take a look.
↗
April 23, 2025
These stocks have an unusual volume in today's session
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
April 23, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
December 04, 2024
Via
Benzinga
Relmada Therapeutics Stock Plummets Losing 80% Value - Here's Why
↗
December 04, 2024
Relmada Therapeutics reports interim analysis of the Phase 3 Reliance II study for REL-1017 in major depressive disorder, indicating futility in meeting efficacy goals.
Via
Benzinga
Nasdaq Surges 150 Points; ISM Services PMI Falls In November
↗
December 04, 2024
Via
Benzinga
Earnings Scheduled For March 27, 2025
↗
March 27, 2025
Via
Benzinga
Dow Gains 250 Points; Salesforce Shares Jump After Q3 Results
↗
December 04, 2024
Via
Benzinga
Topics
Stocks
RLMD Stock Earnings: Relmada Therapeutics Beats EPS for Q2 2024
↗
August 07, 2024
RLMD stock results show that Relmada Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Keurig Dr Pepper To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
↗
June 05, 2024
Via
Benzinga
7 Penny Biotech Stocks to Triple Your Investment
↗
May 28, 2024
Biotech penny stocks offer the chance to triple your investments and require an appetite for risk in order to capture returns.
Via
InvestorPlace
RLMD Stock Earnings: Relmada Therapeutics Beats EPS for Q1 2024
↗
May 08, 2024
RLMD stock results show that Relmada Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
RLMD Stock Earnings: Relmada Therapeutics Misses EPS for Q4 2023
↗
March 19, 2024
RLMD stock results show that Relmada Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Earnings Scheduled For March 19, 2024
↗
March 19, 2024
Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per share on revenue of $931.97 million.
Via
Benzinga
Relmada Therapeutics And 2 Other Penny Stocks Insiders Are Buying
↗
February 01, 2024
The Dow Jones index closed lower by more than 300 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...
Via
Benzinga
Topics
Stocks
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
January 04, 2024
Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
January 04, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
October 04, 2023
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
September 21, 2023
Via
Benzinga
Relmada Therapeutics' Lead Candidate Shows Promise In Pivotal Depression Study
↗
September 20, 2023
Relmada Therapeutics Inc (NASDAQ: RLMD) announced efficacy results for the de novo (or new to treatment) patients (204 patients) and safety results for all subjects (627 patients) from the Phase 3...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today